SignalFDA/Bio

BAYER’S EXPERIMENTAL PET TRACER SHOWS ACCURACY IN PHASE 3 CARDIAC AMYLOIDOSIS - SEEKINGALPHA

Phase 3 data confirms tracer accuracy, a key efficacy catalyst for Bayer.

What changed

Why it matters

Phase 3 data confirms tracer accuracy, a key efficacy catalyst for Bayer.

Sources